# Reetoo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reetoo

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.reetoo.com
- Total disclosed funding: $14M
- Latest round: Series B (Dec 18, 2023)
- Investors on record: 2

## About

Established in 2017 and based in Shenzhen, China, Reetoo is a medical equipment company that focuses on the research, development, and production of AI testing equipment. It has 14,000 square meters of R&D center and production basement, with more than 400 patents. In 2018, the company finished its first production plant. In 2022, it was recognized as a National High-tech Enterprise. In December 2023, Reetoo raised a series B2 funding for over CNY 100 million.

The company's products are AI testing instruments and equipment for 8 categories, including blood, leukorrhea, semen, chromosomes, urine, feces, sputum, and tissues. The products use DeepCell engine, AI vision, AI recognition system, and other technologies. Its products have covered more than 1,500 hospitals across the country.

The company will use the funding to accelerate the marketization of AI testing labs.

## Funding rounds

- Series B, Dec 18, 2023, $14M — CAS Investment Management, Shenzhen Investment Holdings

## Investors

- CAS Investment Management (https://capitalatlas.ai/funds/cas-investment-management) — Series B
- Shenzhen Investment Holdings — Series B